Everise Labs - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 195,446 | 186,569 | 332,620 | 300,540 | 272,013 | 384,643 | 415,671 | 458,682 |
| Profit before tax | 15,818 | -22,750 | 35,769 | 3,852 | -12,238 | 75,061 | 101,641 | 100,578 |
| Net profit | 14,976 | -22,750 | 30,349 | 3,070 | -12,238 | 65,435 | 86,201 | 84,056 |
| Equity | 47,648 | 24,896 | 55,246 | 58,315 | 46,077 | 111,512 | 154,712 | 93,767 |
| Liabilities | 22,731 | 18,815 | 68,290 | 45,735 | 43,068 | 62,271 | 59,588 | 65,857 |
| Non-current assets | 4,351 | 3,990 | 3,990 | 39,958 | 39,563 | 30,247 | 23,682 | 45,203 |
| Current assets | 65,081 | 36,093 | 110,628 | 58,786 | 44,784 | 137,251 | 185,965 | 109,670 |
| Total assets | 69,432 | 40,083 | 114,618 | 98,744 | 84,347 | 167,498 | 209,647 | 154,873 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 58,324 | 94,286 | 121,953 |
| Social insurance contributions | - | - | - | - | - | 9,023 | - | 34,782 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | -4.5% | +78.3% | -9.6% | -9.5% | +41.4% | +8.1% | +10.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 21.6% | -56.8% | 26.5% | 3.1% | -14.5% | 39.1% | 41.1% | 54.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 31.4% | -91.4% | 54.9% | 5.3% | -26.6% | 58.7% | 55.7% | 89.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.7% | -12.2% | 9.1% | 1.0% | -4.5% | 17.0% | 20.7% | 18.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.1% | -12.2% | 10.8% | 1.3% | -4.5% | 19.5% | 24.5% | 21.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.8 | 1.2 | 0.8 | 0.9 | 0.6 | 0.4 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 97,723 | 93,285 | 166,310 | 150,270 | 125,543 | 139,870 | 151,153 | 122,315 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Everise Labs - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-18 | 2024-12-03 | 0.45 |
| 2024-10-16 | 2024-11-03 | 0.45 |
| 2024-09-17 | 2024-09-30 | 0.45 |
| 2024-08-19 | 2024-09-02 | 0.45 |
| 2024-07-16 | 2024-07-31 | 0.45 |
| 2024-06-18 | 2024-06-30 | 0.45 |
| 2024-05-16 | 2024-06-02 | 0.45 |
| 2024-04-16 | 2024-05-01 | 0.63 |
| 2024-03-18 | 2024-04-01 | 0.63 |
| 2024-02-19 | 2024-02-29 | 0.63 |
| 2024-01-16 | 2024-01-31 | 0.63 |
| 2023-12-18 | 2024-01-01 | 0.63 |
| 2023-11-16 | 2023-11-30 | 0.63 |
| 2023-10-27 | 2023-11-02 | 0.63 |
| 2023-10-25 | 2023-10-25 | 0.63 |
| 2023-09-18 | 2023-09-20 | 359.73 |
Everise Labs - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-08 | 2026-03-08 | 7635.15 |
| 2026-03-02 | 2026-03-07 | 7627.71 |
| 2026-02-27 | 2026-03-01 | 4318.13 |
| 2026-02-21 | 2026-02-26 | 7161.36 |
| 2025-08-28 | 2025-08-30 | 0.02 |
| 2025-08-22 | 2025-08-25 | 5247.18 |
| 2025-04-28 | 2025-05-20 | 1.95 |
| 2025-04-17 | 2025-04-23 | 1.95 |
| 2025-04-14 | 2025-04-16 | 14.61 |
| 2025-04-11 | 2025-04-13 | 2421.61 |
| 2025-04-08 | 2025-04-10 | 2409.91 |
| 2025-03-28 | 2025-04-07 | 2.91 |
| 2025-03-19 | 2025-03-19 | 9003.03 |
| 2025-02-28 | 2025-03-18 | 3.03 |
| 2025-01-30 | 2025-02-18 | 2.91 |
| 2024-12-31 | 2025-01-15 | 3.03 |
| 2024-12-30 | 2024-12-30 | 4643.28 |
| 2024-10-10 | 2024-10-16 | 2272.8 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Everise Labs, UAB (code 135581018) is a Private Limited Liability Company engaged in other computer programming activities. In the latest financial year, 2025, the company generated revenue of €458.7K and net profit of €84.1K, corresponding to a profit margin of 18.3%. Revenue increased from €384.6K in 2023 to €415.7K in 2024 and then to €458.7K in 2025, showing steady growth over the period. Net profit also rose from €65.4K in 2023 to €86.2K in 2024, before easing slightly in 2025 while remaining solidly positive. The 2025 balance sheet shows total assets of €154.9K, equity of €93.8K and liabilities of €65.9K, with an equity ratio of 60.5% and debt-to-equity of 0.70. Asset turnover stood at 2.96x, indicating efficient use of assets. Profitability remains strong, with ROE at 89.6% and ROA at 54.3%. Revenue per employee was €152.9K and profit per employee €28.0K in 2025, pointing to a productive operating profile.